全文获取类型
收费全文 | 749篇 |
免费 | 41篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 68篇 |
妇产科学 | 3篇 |
基础医学 | 76篇 |
口腔科学 | 28篇 |
临床医学 | 101篇 |
内科学 | 152篇 |
皮肤病学 | 22篇 |
神经病学 | 15篇 |
特种医学 | 184篇 |
外科学 | 36篇 |
综合类 | 24篇 |
预防医学 | 35篇 |
眼科学 | 14篇 |
药学 | 33篇 |
中国医学 | 1篇 |
肿瘤学 | 29篇 |
出版年
2024年 | 1篇 |
2023年 | 1篇 |
2022年 | 2篇 |
2021年 | 8篇 |
2020年 | 3篇 |
2019年 | 8篇 |
2018年 | 16篇 |
2017年 | 12篇 |
2016年 | 10篇 |
2015年 | 18篇 |
2014年 | 11篇 |
2013年 | 27篇 |
2012年 | 14篇 |
2011年 | 8篇 |
2010年 | 41篇 |
2009年 | 37篇 |
2008年 | 12篇 |
2007年 | 19篇 |
2006年 | 15篇 |
2005年 | 33篇 |
2004年 | 11篇 |
2003年 | 2篇 |
2002年 | 8篇 |
2001年 | 12篇 |
2000年 | 10篇 |
1999年 | 18篇 |
1998年 | 47篇 |
1997年 | 46篇 |
1996年 | 48篇 |
1995年 | 33篇 |
1994年 | 40篇 |
1993年 | 35篇 |
1992年 | 11篇 |
1991年 | 14篇 |
1990年 | 7篇 |
1989年 | 22篇 |
1988年 | 43篇 |
1987年 | 19篇 |
1986年 | 15篇 |
1985年 | 28篇 |
1984年 | 6篇 |
1983年 | 2篇 |
1982年 | 6篇 |
1981年 | 8篇 |
1980年 | 8篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1976年 | 12篇 |
1975年 | 3篇 |
排序方式: 共有826条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
D Gómez-Garre P Mu?oz-Pacheco ML González-Rubio P Aragoncillo R Granados A Fernández-Cruz 《British journal of pharmacology》2009,156(8):1218-1227
Background and purpose:
Ezetimibe, a selective inhibitor of intestinal cholesterol absorption, might also suppress inflammatory components of atherogenesis. We have studied the effects of ezetimibe on two characteristics of atherosclerotic plaques (infiltrate and fibrosis) and on expression of inflammatory genes in a rabbit model of accelerated atherosclerosis.Experimental approach:
Femoral atherosclerosis was induced by a combination of endothelial desiccation and atherogenic diet. Animals were randomized to ezetimibe (0.6 mg·kg−1·day−1), simvastatin (5 mg·kg−1·day−1), ezetimibe plus simvastatin or no treatment, still on atherogenic diet. A control group of rabbits received normolipidemic diet.Key results:
Rabbits fed the normolipidemic diet showed normal plasma lipid levels. Either the normolipidemic diet or drug treatment reduced the intima/media ratio (normolipidemic diet: 22%, ezetimibe: 13%, simvastatin: 27%, ezetimibe + simvastatin: 28%), compared with rabbits with atherosclerosis. Ezetimibe also decreased macrophage content and monocyte chemoattractant protein-1 expression in atherosclerotic lesions. Furthermore, ezetimibe reduced the increased activity of nuclear factor κB in peripheral blood leucocytes and plasma C-reactive protein levels in rabbits with atherosclerosis. In THP-1 cells, ezetimibe decreased monocyte chemoattractant protein-1-induced monocyte migration. Importantly, the combination of ezetimibe with simvastatin was associated with a more significant reduction in plaque monocyte/macrophage content and some proinflammatory markers than observed with each drug alone.Conclusions and implications:
Ezetimibe had beneficial effects both on atherosclerosis progression and plaque stabilization and showed additional anti-atherogenic benefits when combined with simvastatin. Its effect on monocyte migration provides a potentially beneficial action, in addition to its effects on lipids. 相似文献95.
Yip Ronald ML Cheung Tommy T So Ho Chan Julia PS Ho Carmen TK Tsang Helen HL Yu Carrel KL Wong Priscilla CH 《Clinical rheumatology》2023,42(8):2013-2027
Clinical Rheumatology - Gout is one of the most common noncommunicable diseases in Hong Kong. Although effective treatment options are readily available, the management of gout in Hong Kong remains... 相似文献
96.
97.
98.
99.
Fifteen allograft transplant recipients acquired lymphoproliferative disorders after immunosuppressive therapy with cyclosporine and steroids. Many of these lymphoproliferative disorders regressed or disappeared completely after reduction of cyclosporine dose. This disease has several aspects that distinguish it from usual posttransplantation lymphomas that occur with regimens that do not contain cyclosporine. The time course from transplantation to onset of lymphoma is relatively short, with an average of approximately 8 months. Organs show a wide spectrum of abnormalities typical of other immunosuppression-associated lymphomas, but there is unique sparing of the central nervous system. The tumor is also unique in that it responds to a decrease in the cyclosporine dose. 相似文献